This library is a collection of documents that the MATRIX panel and secretariat have used in their research. If you are looking for reports that MATRIX has produced, please visit our Reports section. Click on the subjects below to refine your search.
In this paper we present a snapshot of how Northern Ireland is already proactively involved in precision medicine development, how it is primed to expand this contribution, and why increasing numbers of national and global organisations are partnering with Northern Ireland to realise the full benefits precision medicine can deliver.
The UK has a productivity problem. The size of the problem is well understood, even if the exact causes are not.
Technology and Innovation Futures is a forward look at a range of developments that have the potential to support sustained economic growth in the UK over the next 20 years.
The new rules and legislation governing the next round of EU Cohesion Policy investment for 2014-2020 have been formally endorsed by the Council of the European Union in December 2013. This factsheet is one in a series highlighting key elements of the new approach.
This report reviews recently published international public sector strategies, roadmaps and initiatives related to advanced materials research and innovation.
The SSA for the Digital Economy defines the contributions of digital skills to society and the economy.
The House of Lords Select Committee on Digital Skills published its report, 'Make or Break: The UK’s Digital Future', which warns that the UK is not addressing its significant skills shortage and the incoming Government of 2015 urgently needs to resolve this.
This 2014 report contains statistics and analysis of the Northern Ireland communications sector and is a reference for industry, stakeholders and consumers.
This paper is a five year update and progress report on the original ABPI 2009 White Paper which explored how public and private bodies engaged in biomedical research in the UK could work together to realise the significant benefits to the healthcare system and UK plc that will accrue by accelerating the development and adoption of stratified medicine.